Abstract
Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Ganglionic Stimulants / administration & dosage
-
Humans
-
Nicotine / administration & dosage
-
Public Health / legislation & jurisprudence*
-
Tobacco Industry / legislation & jurisprudence*
-
Tobacco Use Disorder / prevention & control*
-
United States
-
United States Food and Drug Administration
Substances
-
Ganglionic Stimulants
-
Nicotine